Group items tagged

That’s a large gamble based on very little scientific understanding.

Contrary to the popular understanding, Sweden has not done nothing. Social distancing is in place, people are to work from home where possible and to isolate when even mildly symptomatic. Steps have been taken to shield vulnerable citizens

WHO mortality data shows Italy, the United Kingdom, Spain and the United States all have higher death rates, despite having imposed significant mitigation and suppression protocols.

by traditional metrics of deaths/capita, cases/capita, or even crude case fatality rate, they ended up seemingly in a worse position than Sweden, where bars remain open and coffee culture is booming.

A strategy should be based on a broad empirically derived consensus which takes into account both what we know, and what we do not.

We don’t know how many people have a strong immune response to the virus.

From inside this tunnel we do not know how many people are now tied to the track. We do not know how far the line runs. Or even what the final destination looks like. Sweden’s strategic inaction was predicated on the hope that they might save lives in future by taking risks now and avoiding a shutdown.

We don’t know how many people have been infected and how those infections might manifest.

We don’t know how many individuals need immunity to produce effective herd immunity.

And we don’t know if immunity to the current strain would carry over to future strains.

Even more bracing: We are unlikely to find definitive answers to these questions in the near future.

One of the key perceived advantages of Sweden’s approach was the expected reduction in economic damage. But Sweden’s economy is projected to contract by 7 percent to 10 percent of GDP this year, only slightly better than its Nordic neighbors who shut down their societies and have far less morbidity and mortality

All of that said, it is unlikely that we’ll be able to say definitively whether or not Sweden’s choice was optimal any time soon. Even comparing key metrics like cases and deaths between countries is difficult because of methodological differences in collecting data

When we consider economic damages, long-term sequelae of infection and the differential impact across marginalized groups, direct comparisons becomes extremely challenging.

sometimes there are no good decisions; only less bad ones. Sweden may be on the road to herd immunity but even if they are in fact on the path, the road is neither swift nor smooth. And it is littered with friends and relatives.

Juul is the logical extension of the Silicon Valley growth-hacking playbook: Design a flawless product, add a dopamine response, stir in some influencers and watch your product, game or app go viral.

Consider the outcry last week when TechCrunch reported that Facebook had been paying people (including teens) $20 a month to download an app that monitors a user’s mobile and web activity. Apple, long a privacy advocate and favored troll of Facebook, reacted swiftly by cutting off “Facebook Research” and the company’s internal apps. Tech Twitter, however, seemed largely perplexed: In the future, won’t we all sell our data rather than give it away for free?

If Silicon Valley was once converging on a moral cohesion of sorts — where progressive values and wokemanship acted as a loose ethical framework — it’s now becoming harder to avoid the varying ethical debates concerning privacy, addiction and growing geopolitical discord.

For the virtuous founders avoiding addictive products and invasive data-gathering, even they have to worry about who’s getting on their equity ownership table.

founders have to wonder whether that seemingly diverse venture capital fund is backed by regimes where women, minorities and dissidents are killed for expressing themselves.

of course, the morality of a company often depends on the morality of the people in charge